WinstonWınston
PACS Group logo

PACS Group

PACS
59
Financial - Conglomerates · Financial Services
Winston Score
59
Winston is curious
A decent business — some strong pillars, some weaker.

PACS Group operates skilled nursing facilities and other post-acute care centers across the United States. These are places where patients go after leaving a hospital — for example, after a surgery or serious illness — to recover and get medical care before going home. The company serves elderly and medically complex patients, and most of its revenue comes from government programs like Medicare and Medicaid.

PACS makes money by charging for daily patient care, with reimbursement rates set largely by federal and state governments rather than by the company itself. It operates primarily in the western United States and has grown quickly by acquiring existing facilities. Its competitive position depends on maintaining high occupancy rates and managing costs tightly, since margins in skilled nursing are thin. The biggest risk the company faces is government reimbursement cuts, as any reduction in Medicare or Medicaid payment rates would directly reduce revenue and profitability.

Winston Score History

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+11.2% YoY

YoY Growth Rate

Steady revenue growth

EPS Growth

+183.3% YoY

YoY Growth Rate

EPS growth accelerating

Insider Activity

70.1%ownership

Insiders own a meaningful stake in the company

Cash Position

Cash flow positive

$248M cash & investments

Quarterly Free Cash Flow

↑ Burn rate improving

Company generates more cash than it spends — no dilution risk from fundraising

Growth + cash flow

PACS Group is a rare growth stock that's already generating positive cash flow while growing at 11%. The Winston Score doesn't fully credit this transition from "burner" to "earner."

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
16.4%
Thin — 16.4% gross margin
Operating Margin
8.5%
Modest — 8.5% operating margin
ROCE
2.9%
Weak — 2.9% return on capital

ROIC between 0% and 5%. They earn a few cents back per dollar invested in the business.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
+20.9%
Fast-growing sales (20.9% YoY)
EPS YoY
+246.8%
Earnings growing fast (246.8% YoY)

Earnings growing 25%+ a year. The compounder zone.

EPS Consistency
8/8 quarters
Every recent quarter grew earnings vs last year

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
201%
Turns 201% of profit into real cash
FCF Margin
4.4%
Thin free cash flow (4.4%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
2.99
Heavy debt load (2.99)
Interest Cover
13.68x
Comfortably covers interest (13.7x)

Interest coverage above 8. Profits cover interest many times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
29.0x
no trend
Growth-priced — P/E 29.0

P/E above the market average. People are paying up for expected growth.

P/E vs Forward
+13.0
GROWING
Earnings expected to grow meaningfully — cheaper on forward P/E (29.0 → 16.1)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial